Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | GMAB | JAZZ | ||
| Company | Ascendis Pharma ADR | Genmab A/S ADR | Jazz Pharma Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 252.72 | 28.05 | 244.65 | ||
| High | 257.12 | 28.55 | 255.20 | ||
| Low | 250.03 | 27.98 | 242.11 | ||
| Latest | 255.20 | 28.36 | 254.22 | ||
| Change | +3.44 | +0.45 | +10.75 | ||
| % Change | +1.37% | +1.61% | +4.42% | ||
| Volume | 549,000 | 871,600 | 809,900 | ||
| 20-Day Average Volume | 899,505 | 2,058,335 | 773,055 | ||
| Previous Close | 251.76 | 27.91 | 243.47 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 262.84 | 27.99 | 240.43 | ||
| 20-Day Raw Stochastic | 54.58% | 67.75% | 96.96% | ||
| 20-Day Relative Strength | 52.70 | 55.63 | 63.69 | ||
| Weighted Alpha | +46.99 | +14.72 | +109.43 | ||
| Today's Opinion | 88% Buy | 8% Sell | 100% Buy | ||
| Previous Opinion | 88% Buy | 8% Sell | 100% Buy | ||
| Last Month's Opinion | 40% Buy | 100% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.90% since 07/14/26 | -1.29% since 07/14/26 | +6.79% since 07/14/26 | ||
| Low | 250.03 on 07/21/26 | 27.86 on 07/20/26 | 233.46 on 07/15/26 | ||
| High | 268.77 on 07/15/26 | 29.29 on 07/15/26 | 255.20 on 07/21/26 | ||
| 1-Month | |||||
| %Chg | +10.56% since 06/18/26 | +12.23% since 06/18/26 | +13.16% since 06/18/26 | ||
| Low | 222.82 on 06/23/26 | 24.88 on 06/22/26 | 222.93 on 06/23/26 | ||
| High | 282.15 on 07/09/26 | 29.80 on 07/09/26 | 255.20 on 07/21/26 | ||
| 3-Month | |||||
| %Chg | +6.21% since 04/21/26 | +4.80% since 04/21/26 | +27.73% since 04/21/26 | ||
| Low | 203.80 on 06/08/26 | 23.62 on 06/03/26 | 194.77 on 04/24/26 | ||
| High | 282.15 on 07/09/26 | 29.80 on 07/09/26 | 255.20 on 07/21/26 | ||
| 6-Month | |||||
| %Chg | +17.79% since 01/21/26 | -13.93% since 01/21/26 | +50.28% since 01/21/26 | ||
| Low | 203.80 on 06/08/26 | 23.62 on 06/03/26 | 161.38 on 02/11/26 | ||
| High | 282.15 on 07/09/26 | 34.68 on 01/27/26 | 255.20 on 07/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,704,031 | 17,402,806 | 15,294,299 | ||
| Shares Outstanding, K | 62,377 | 623,533 | 62,818 | ||
| Annual Sales | 814,760,000 | 3,720,000,000 | 4,267,590,000 | ||
| Annual Net Income | -258,000,000 | 963,000,000 | -356,150,000 | ||
| Last Quarter Sales | 288,620,000 | 896,000,000 | 1,068,900,000 | ||
| Last Quarter Net Income | 736,580,000 | 53,000,000 | 293,100,000 | ||
| 60-Month Beta | 0.37 | 0.84 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.32 on 05/07/26 | 0.15 on 05/07/26 | 6.34 on 05/05/26 | ||
| Earnings Date | 08/06/26 | 08/06/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.66 | 27.08 | ||